On August 6, Albemarle rose 5.17% in pre-market trading, trading at $124.39/share, with turnover of $373,700.

On the news front, Albemarle reported Q2 adjusted earnings of $3.75 per diluted share, surpassing the analyst consensus estimate of $3.24 by approximately 15.7%, and representing a dramatic increase from $0.11 per share in the year-ago quarter. Revenue for the three months ended June 30 came in at $1.743 billion, exceeding the $1.603 billion estimate and up from $1.33 billion a year earlier.

In addition to the earnings beat, the company raised its full-year specialties segment revenue guidance to a range of $1.4 billion to $1.6 billion, while also lifting adjusted EBITDA expectations for the segment to $275 million to $325 million. The upward revision reflects continued momentum in specialties and energy storage markets, building on a strong Q1 where net sales grew 33% year-over-year driven by both volume and pricing improvements in the lithium business.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)